⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14933753 | 0.69 | — | — | |
| SCHEMBL12656451 | 0.67 | — | — | |
| SCHEMBL9188265 | 0.63 | — | — | |
| SCHEMBL17056203 | 0.63 | — | — | |
| SCHEMBL18583473 | 0.62 | — | — | |
| SCHEMBL18271851 | 0.61 | — | — | |
| SCHEMBL18403622 | 0.61 | — | — | |
| SCHEMBL14233386 | 0.61 | — | — | |
| SCHEMBL14399857 | 0.60 | — | — | |
| SCHEMBL23673185 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2295054-A1 | Ice inhibitors for the treatment of autoinflammatory diseases | Vertex Pharmaceuticals Incorporated (US) | 2011-03-16 | — | — | EP | disclosed |
| WO-2010086622-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010086603-A1 | ENZYME MUTANT | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010086602-A1 | HYBRIDIZATION LINKERS | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2010-08-05 | — | — | WO | disclosed |